17.05.2011 • News • generics • Pharma • Shlomo Yanai

Teva CEO Shlomo Yanai Says Always Looking for More Acquisitions

Teva CEO Shlomo Yanai
Teva CEO Shlomo Yanai

Teva Pharmaceutical Industries is always looking for acquisitions and will move on other potential targets when it finds a strategic fit, its top executive said on Monday.

"We are scrutinizing constantly the opportunities and in due time we will move for further acquisitions when we find them a ... strategic fit," Teva CEO Shlomo Yanai said at a briefing in Tokyo.

Teva said on Monday that it would acquire 57% of privately held Taiyo Pharmaceutical Industry for $460 million in cash and would make an offer to buy the remaining shares of Japan's third-largest generic pharmaceutical company.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature